Cargando…

Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study

PURPOSE: To evaluate the efficacy of half-dose photodynamic therapy (PDT) for the treatment of bullous retinal detachment. METHODS: Interventional prospective case series in six eyes from six consecutive patients with bullous retinal detachment. The effected eyes were treated with indocyanine green...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tingting, Qu, Jinfeng, Xiao, Jing, Hu, Jie, Zhao, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060766/
https://www.ncbi.nlm.nih.gov/pubmed/29869216
http://dx.doi.org/10.1007/s00417-018-4015-8
_version_ 1783342081035468800
author Gao, Tingting
Qu, Jinfeng
Xiao, Jing
Hu, Jie
Zhao, Mingwei
author_facet Gao, Tingting
Qu, Jinfeng
Xiao, Jing
Hu, Jie
Zhao, Mingwei
author_sort Gao, Tingting
collection PubMed
description PURPOSE: To evaluate the efficacy of half-dose photodynamic therapy (PDT) for the treatment of bullous retinal detachment. METHODS: Interventional prospective case series in six eyes from six consecutive patients with bullous retinal detachment. The effected eyes were treated with indocyanine green angiography (ICGA)-guided half-dose PDT with multifocal and large laser spots. Clinical evaluations included best-corrected visual acuity (BCVA), ophthalmoscopy, ophthalmic B scan, fundus fluorescein angiography (FFA), optical coherence tomography (OCT), and ICGA at each scheduled visit at baseline; at 1, 3, and 6 months after PDT; and during follow-up after 6 months. RESULTS: All six eyes received half-dose verteporfin PDT with a mean number of therapeutic spots 2.83 ± 1.47 and a mean spot size of 4647 ± 996 μm in diameter. Three months after PDT, retinal reattachment was observed on B scans and resolution of sub-retinal fluid (SRF) was observed in OCT images for five eyes. There was no significant difference in the mean logMAR BCVA between the baseline and the value at 1 month after PDT (P = 0.477). At 3 months after PDT, the mean logMAR BCVA improved significantly from a baseline value of 1.02 to 0.54 (P = 0.044). At 6 months after PDT, the mean logMAR BCVA further improved to 0.46 (P = 0.025) and remained stable. One affected eye received a second half-dose PDT for SRF not reduced until the second month after PDT. Retinal reattachment and SRF resolution were observed at 1 and 3 months after the second therapy, respectively. BCVA improved from a baseline value of 20/63 to 20/20 at 1 month after the second PDT and remained stable until the sixth month after the second PDT. During follow-up after more than 6 months, recurrence occurred in no cases. CONCLUSIONS: This study demonstrated half-dose PDT with multifocal and large laser spots was an effective treatment for bullous retinal detachment contributing to the retinal reattachment, a resolution of SRF, and an improvement of BCVA. Thus, PDT for the treatment of bullous retinal detachment is considered to be a worthwhile endeavor.
format Online
Article
Text
id pubmed-6060766
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-60607662018-08-09 Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study Gao, Tingting Qu, Jinfeng Xiao, Jing Hu, Jie Zhao, Mingwei Graefes Arch Clin Exp Ophthalmol Retinal Disorders PURPOSE: To evaluate the efficacy of half-dose photodynamic therapy (PDT) for the treatment of bullous retinal detachment. METHODS: Interventional prospective case series in six eyes from six consecutive patients with bullous retinal detachment. The effected eyes were treated with indocyanine green angiography (ICGA)-guided half-dose PDT with multifocal and large laser spots. Clinical evaluations included best-corrected visual acuity (BCVA), ophthalmoscopy, ophthalmic B scan, fundus fluorescein angiography (FFA), optical coherence tomography (OCT), and ICGA at each scheduled visit at baseline; at 1, 3, and 6 months after PDT; and during follow-up after 6 months. RESULTS: All six eyes received half-dose verteporfin PDT with a mean number of therapeutic spots 2.83 ± 1.47 and a mean spot size of 4647 ± 996 μm in diameter. Three months after PDT, retinal reattachment was observed on B scans and resolution of sub-retinal fluid (SRF) was observed in OCT images for five eyes. There was no significant difference in the mean logMAR BCVA between the baseline and the value at 1 month after PDT (P = 0.477). At 3 months after PDT, the mean logMAR BCVA improved significantly from a baseline value of 1.02 to 0.54 (P = 0.044). At 6 months after PDT, the mean logMAR BCVA further improved to 0.46 (P = 0.025) and remained stable. One affected eye received a second half-dose PDT for SRF not reduced until the second month after PDT. Retinal reattachment and SRF resolution were observed at 1 and 3 months after the second therapy, respectively. BCVA improved from a baseline value of 20/63 to 20/20 at 1 month after the second PDT and remained stable until the sixth month after the second PDT. During follow-up after more than 6 months, recurrence occurred in no cases. CONCLUSIONS: This study demonstrated half-dose PDT with multifocal and large laser spots was an effective treatment for bullous retinal detachment contributing to the retinal reattachment, a resolution of SRF, and an improvement of BCVA. Thus, PDT for the treatment of bullous retinal detachment is considered to be a worthwhile endeavor. Springer Berlin Heidelberg 2018-06-04 2018 /pmc/articles/PMC6060766/ /pubmed/29869216 http://dx.doi.org/10.1007/s00417-018-4015-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Retinal Disorders
Gao, Tingting
Qu, Jinfeng
Xiao, Jing
Hu, Jie
Zhao, Mingwei
Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title_full Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title_fullStr Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title_full_unstemmed Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title_short Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
title_sort photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
topic Retinal Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060766/
https://www.ncbi.nlm.nih.gov/pubmed/29869216
http://dx.doi.org/10.1007/s00417-018-4015-8
work_keys_str_mv AT gaotingting photodynamictherapyforbullousretinaldetachmentasinglecenterexperienceofcaseserieswitha6monthfollowupstudy
AT qujinfeng photodynamictherapyforbullousretinaldetachmentasinglecenterexperienceofcaseserieswitha6monthfollowupstudy
AT xiaojing photodynamictherapyforbullousretinaldetachmentasinglecenterexperienceofcaseserieswitha6monthfollowupstudy
AT hujie photodynamictherapyforbullousretinaldetachmentasinglecenterexperienceofcaseserieswitha6monthfollowupstudy
AT zhaomingwei photodynamictherapyforbullousretinaldetachmentasinglecenterexperienceofcaseserieswitha6monthfollowupstudy